World's Best Scientists 2026 revealed!
Marie-Françoise Avril

Marie-Françoise Avril

Overview

Marie-Françoise Avril is affiliated with Université Paris Cité in France. Their research focuses extensively on medicine and the biochemistry, genetics, and molecular biology domains, with particular emphasis on oncology, molecular biology, surgery, genetics, and immunology.

The scientist's work covers multiple topics, including:

  • Genetic Associations and Epidemiology
  • Mast cells and histamine
  • Cutaneous Melanoma Detection and Management
  • Renal cell carcinoma treatment
  • Cancer Genomics and Diagnostics
  • Renal and related cancers
  • Melanoma and MAPK Pathways

Recent publications by Marie-Françoise Avril include:

  • Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility, 2020, Nature Genetics
  • BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis, 2020, Journal for ImmunoTherapy of Cancer
  • The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma, 2021, Cancers
  • Le lambeau de Rieger-Marchac: complications et satisfaction des patients, 2020, Annales de Dermatologie et de Vénéréologie

Frequent co-authors collaborating with Marie-Françoise Avril include:

  • E. Maubec
  • Maria Teresa Landi
  • D. Timothy Bishop
  • Stuart MacGregor
  • Mitchell J. Machiela

The research output has been published in several venues, notably:

  • Nature Genetics
  • Cancers
  • Journal for ImmunoTherapy of Cancer
  • Annales de Dermatologie et de Vénéréologie

Best Publications

  • Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.

    Marie Françoise Avril;S. Aamdal;J. J. Grob;A. Hauschild

  • A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

    Corine Bertolotto;Fabienne Lesueur;Sandy Giuliano;Thomas Strub

  • HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance

    P Paul;N Rouas-Freiss;I Khalil-Daher;P Moreau

  • Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome

    Véronique Winnepenninckx;Vladimir Lazar;Stefan Michiels;Philippe Dessen

  • Genome-wide association study identifies three loci associated with melanoma risk.

    D Timothy Bishop;Florence Demenais;Mark M Iles;Mark Harland

  • High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL

    Alisa M. Goldstein;May Chan;Mark Harland;Elizabeth M. Gillanders

  • Prevalence of p16 and CDK4 Germline Mutations in 48 Melanoma-Prone Families in France

    Nadem Soufir;Marie-Françoise Avril;Agnès Chompret;Florence Demenais

  • Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

    Eve Maubec;Peter Petrow;Isabelle Scheer-Senyarich;Pierre Duvillard

  • Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs.

    Dirk Schadendorf;Celeste Lebbe;Axel zur Hausen;Marie-Francoise Avril

  • Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study

    M. F. Avril;A. Auperin;A. Margulis;A. Gerbaulet

  • Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.

    Jianxin Shi;Xiaohong R. Yang;Bari Ballew;Melissa Rotunno

  • Germline BAP1 mutations predispose to renal cell carcinomas.

    Tatiana Popova;Lucie Hebert;Virginie Jacquemin;Sophie Gad

  • Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: Clinicopathologic Features and Prognostic Analysis in 60 Cases

    Florent Grange;Marie Beylot-Barry;Phillipe Courville;Eve Maubec

  • Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis.

    Xavier Sastre-Garau;Martine Peter;Marie-Françoise Avril;Hélène Laude

  • Genome-wide association study identifies three new melanoma susceptibility loci

    Jennifer H. Barrett;Mark M. Iles;Mark Harland;John C. Taylor

  • Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.

    Ulrich Keilholz;Christian Conradt;Sewa S Legha;David Khayat

  • Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control

    Michelle Hong;Anne Laure Puaux;Caleb Huang;Laure Loumagne

  • Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: A clinical report

    Marie Marchand;Marie Marchand;C. J.A. Punt;Steinar Aamdal;B. Escudier

  • CD4+ CD56+ Cutaneous Neoplasms: A Distinct Hematological Entity?

    Tony Petrella;Sophie Dalac;Marc Maynadié;Francine Mugneret

  • Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma

    Matthew H. Law;D. Timothy Bishop;Jeffrey E. Lee;Myriam Brossard

Frequent Co-Authors

Nicolas Dupin
Nicolas Dupin Université Paris Cité
Florence Demenais
Florence Demenais Université Paris Cité
Brigitte Bressac-de Paillerets
Brigitte Bressac-de Paillerets Institut Gustave Roussy
Susana Puig
Susana Puig University of Barcelona
Pierre Duvillard
Pierre Duvillard Institut Gustave Roussy
Nicholas K. Hayward
Nicholas K. Hayward QIMR Berghofer Medical Research Institute
Håkan Olsson
Håkan Olsson Lund University
Pascal Joly
Pascal Joly University of Rouen
Nelleke A. Gruis
Nelleke A. Gruis Leiden University Medical Center
Graham J. Mann
Graham J. Mann Australian National University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future in Medicine doesn’t have to follow just one path. A range of health administration degree programs are available online, helping students develop leadership skills for roles outside of direct patient care. These programs focus on topics like healthcare policy, operations, and financial management.

For registered nurses looking to advance, rn to np bridge programs offer an efficient route to become a nurse practitioner, blending clinical practice with advanced coursework, often entirely online. This flexibility allows nurses to keep working as they move up the career ladder.

For those passionate about diet, wellness, and preventive care, an online bachelor's degree in nutrition can open up opportunities in healthcare settings, public health, or private practice. Online study supports a flexible learning environment for busy students.

If your goal is executive healthcare leadership, online mha programs that are CAHME-accredited ensure students receive high-quality training recognized by employers. Choosing the right online degree or pathway can help align your education with your long-term career objectives in the health sector.

Best Scientists Citing Marie-Françoise Avril

Trending Scientists

Recently Published Articles